Neuland Laboratories is a leading, global active pharmaceutical ingredient (API) development and manufacturing organization that caters to the pharmaceutical and biotech industry’s chemistry needs. Right from synthesis of pre-clinical compounds to supplying New Chemical Entities (NCEs) and advanced intermediates at various stages in the clinical life cycle, as well as commercials, they offer agile and flexible API manufacturing and development services for small molecules and peptides. They have three cGMP-certified facilities with state-of-the-art equipment for producing APIs and intermediates for Phase I through large Phase III clinical trials. The company has a stellar track record of successful regulatory inspections from the U.S. Food and Drug Administration, PMDA-Japan, EDQM, EMA, KFDA, TGA, ANVISA Brazil and AFSSAPS (France). Neuland is reliable manufacturing and development partner to customers in over 80 countries across US, Europe, Japan, APAC, India, MENA and LATAM.